Financial insights of HBIO

MyFinsight

For the quarter ending 2025-09-30, HBIO made $20,591K in revenue. -$1,231K in net income. Net profit margin of -5.98%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Revenues	20,591	20,450	21,774	21,970
Cost of revenues	8,570	8,917	9,590	9,205
Gross profit	12,021	11,533	12,184	12,765
Sales and marketing expenses	4,613	4,539	4,971	5,518
General and administrative expenses	4,176	4,262	5,185	5,041
Research and development expenses	2,132	2,189	2,321	2,567
Amortization of acquired intangible assets	855	1,162	1,160	1,334
Goodwill impairment - note 4	0	0	47,951	-
Other operating expenses - note 1	48	200	264	179
Total operating expenses	11,824	12,352	61,852	14,639
Operating income (loss)	197	-819	-49,668	-1,874
Interest expense	-966	-791	-802	-856
Loss on pension settlement	0	-	-	1,243
Loss on equity securities - note 6	0	0	-	-
Other expense, net	-365	-644	-324	-518
Total other expense	-1,331	-1,435	-1,126	-2,617
Loss before income taxes	-1,134	-2,254	-50,794	-4,491
Income tax expense (benefit)	97	28	-454	311
Net loss	-1,231	-2,282	-50,340	-4,802

Basic loss per share (in dollars per share)	-0.03	-0.05	-1.14	-0.11
Diluted loss per share (in dollars per share)	-0.03	-0.05	-1.14	-0.11
Us-gaap_weightedaveragenumberofdilutedsharesoutstanding	44,556,000	44,303,000	44,096,000	43,614,000
Weighted average shares outstanding - basic (in shares)	44,556,000	44,303,000	44,096,000	43,614,000